Effect of continuous sequential transdermal estradiol/norethisterone acetate vs. estradiol HRT on bone markers in postmenopausal women

被引：0

作者：

Delmas, P

Archer, DF

机构：

[1] Hop Edouard Herriot, Serv Rhumatol, Lyon, France

[2] Eastern Virginia Med Sch, Dept Obstet & Gynecol, Norfolk, VA 23501 USA

来源：

OSTEOPOROSIS INTERNATIONAL | 2000年 / 11卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S62 / S62

页数：1

共 50 条

[41] The effect of medroxyprogesterone acetate and norethisterone on the estradiol stimulated proliferation in MCF-7 cells: comparison of continuous combined versus sequential combined estradiol/progestin treatment
Lippert, C
Seeger, H
Wallwiener, D
Mueck, AO
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2001, 22 (05) : 331 - 335
[42] Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women
Georgiev, DB
Manassiev, NA
MEDSCAPE WOMENS HEALTH, 2002, 7 (04):
[43] The impact of subcutaneous estradiol on markers of bone turnover in postmenopausal women.
Pereda, CA
Hannon, RA
Eastell, R
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S398 - S398
[44] Randomized trial of effects of estradiol in combination with either norethisterone acetate or trimegestone on lipids and lipoproteins in postmenopausal women
Ai-Azzawi, F
Wahab, M
Sami, S
Proudler, AJ
Thompson, J
Stevenson, J
CLIMACTERIC, 2004, 7 (03) : 292 - 300
[45] Bioavailability of norethisterone acetate alone and in combination with estradiol administered in single or multiple oral doses to postmenopausal women
Stadberg, E
Westlund, P
Landgren, BM
Aedo, AR
Cekan, SZ
Mattsson, LÅ
MATURITAS, 1999, 33 (01) : 59 - 69
[46] Metabolic syndrome in postmenopausal women: the influence of oral or transdermal estradiol on inflammation and coagulation markers
Chu, Micheline C.
Cushman, Mary
Solomon, Rachel
Lobo, Rogerio A.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 199 (05) : 526.e1 - 526.e7
[47] Plasma leptin women with in postmenopausal coronary artery disease:: effect of transdermal 17β-estradiol and intermittent medroxyprogesterone acetate
Os, I
Os, A
Abdelnoor, M
Larsen, A
Birkeland, K
Westheim, A
CLIMACTERIC, 2003, 6 (03) : 204 - 210
[48] Low doses of 17 beta-estradiol and norethisterone acetate as continuous combined replacement therapy in postmenopausal women: Lipid metabolic effects
Stadberg, E
Mattsson, LA
Uvebrant, M
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 1996, 3 (02): : 90 - 96
[49] Bleeding profile and endometrial safety of continuous combined regimens 1 mg 17β-estradiol/trimegestone versus 1 or 2 mg 17β-estradiol/norethisterone acetate in postmenopausal women
Bouchard, P
De Cicco-Nardone, F
Spielmann, D
Garcea, N
GYNECOLOGICAL ENDOCRINOLOGY, 2005, 21 (03) : 142 - 148
[50] Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause
Notelovitz, M
Cassel, D
Hille, D
Furst, KW
Dain, MP
VandePol, C
Skarinsky, D
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 182 (01) : 7 - 12

← 1 2 3 4 5 →